结肠癌中Septin9与CD44的表达及临床意义

Expression and clinical significance of Septin9 and CD44 in colon cancer

ES评分 0

DOI 10.12208/j.ijcr.20230362
刊名
International Journal of Clinical Research
年,卷(期) 2023, 7(12)
作者
作者单位

1 佳木斯大学 黑龙江佳木斯 ;
1 佳木斯大学 黑龙江佳木斯 ;
2 佳木斯大学附属第一医院肿瘤综合科 黑龙江佳木斯 ;

摘要
近年来结直肠癌已是全球第三大常见的癌症。结肠癌起病常较隐匿,早期临床表现常不明显,绝大多数患者就诊时已处于肿瘤晚期。癌症干细胞(CSC)以前在多种类型的癌症中发现,结肠癌就是其中之一,它与几种生物标志物相关。与结直肠相关的两个最重要的标志物是 CD44 和 CD133。结肠癌患者的上皮细胞中Septin9的转录本就过表达。本文将从Septin9与CD44在结肠癌中的表达及其临床意义进行阐述。
Abstract
In recent years, colorectal cancer has become the third most common cancer worldwide. The onset of colon cancer is often insidious, the early clinical manifestations are often not obvious, and the vast majority of patients have been in the advanced stage of cancer. Cancer stem cells (CSC) have previously been found in many types of cancer, colon cancer being one of them, and are associated with several biomarkers. The two most important markers associated with colorectal cancer are CD44 and CD133. Septin9 transcripts are overexpressed in epithelial cells of patients with colon cancer. This article will discuss the expression of Septin9 and CD44 in colon cancer and their clinical significance.
关键词
结肠癌;Septin9;CD44;肿瘤干细胞
KeyWord
Colon cancer; Septin9; CD44; Tumor stem cell
基金项目
页码 29-32
  • 参考文献
  • 相关文献
  • 引用本文

宋德旭,,高萱,,窦鹏挥*. 结肠癌中Septin9与CD44的表达及临床意义 [J]. 国际临床研究杂志. 2023; 7; (12). 29 - 32.

  • 文献评论

相关学者

相关机构